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TO THE EDITOR
In contrast to the dynamic and striking
changes in hair follicle (HF) morphol-
ogy during the anagen and catagen
phases of the hair cycle, the telogen
follicle appears static. However, it has
been argued that the quiescent appear-
ance of telogen HFs is deceptive (Davis,
1962; Stenn and Paus, 2001; Higgins
et al., 2009). For example, the expres-
sion of some genes clearly peaks during
telogen (Greco et al., 2009). Also,
functionally distinct subphases of telo-
gen have been identified (‘‘competent’’
versus ‘‘refractory telogen’’) based on
the ability to initiate anagen after
plucking (Plikus et al., 2008).
To gain further insights into the
biological activities of telogen and to
further probe the concept that telogen
represents an important hair cycle–
regulatory phase, we profiled skin
mRNA expression patterns in mid-
(P54) and late (P59) second telogen in
C57BL6 male mice with highly syn-
chronized HF cycling. These data were
analyzed in combination with pre-
viously published hair cycle gene ex-
pression profiling data that included an
early telogen sample (P44; Lin et al.,
2009). Microarray hybridization and
data analyses are described in Supple-
mentary Methods online. As RNA
was prepared from whole skin, subtle
transcriptional changes occurring in a
small population of follicular cells
may not be detected and opposite
changes in different cell populations
may cancel each other. Also, skin sam-
ples used in our study contain subcuta-
neous adipose tissue, recently identified
as critical for extrinsic modulation of
HF behavior (Festa et al., 2011; Plikus
et al., 2011).
While many genes reach their high-
est or lowest expression in telogen skin,
we defined the telogen gene expression
signature more rigorously as genes with
expression 1.5-fold higher or lower in
each of the three telogen time points
compared with all anagen and catagen
time points and P-value less than 0.001
(Supplementary Figure S1 online). The
1.5-fold cutoff was chosen to minimize
false positivity due to changes in tissue
composition. Following these selection
criteria, our microarray analysis re-
vealed 425 differentially expressed
genes (Supplementary Table S1 online).
The 425 genes thus defined reflect the
uniqueness of telogen skin, demonstrat-
ing that telogen is a highly dynamic
hair cycle phase at the level of trans-
criptional regulation, providing new
insights into previously unexplored
biological processes that may drive this
pseudo-quiescent hair cycle stage.
Observed over the whole second hair
cycle, the expression of the telogen
signature genes fell into three major
clusters (Figure 1a), each with unique,
significant (Po0.01) functional cate-
gories (Figure 1b).
Cluster I contains genes upregulated
in telogen; the most prominent gene
ontology categories in this cluster are
proteolysis, rhythmic process, choles-
terol metabolic process, and actino-
myosin structure organization. The
proteolysis category contains several
proteases functioning in shedding of
membrane-associated cytokines and in
macrophage activation. The latter is
consistent with data showing hair cy-
cle–related expression of innate immu-
nity modulators (Stenn and Paus, 2001).
Proteases with enhanced expression in
telogen may also have a role in active
hair fiber detachment during exogen
(Higgins et al., 2009).
The identification of ‘‘rhythmic pro-
cess’’ which includes circadian target
genes extends previous findings, show-
ing that prominent circadian clock gene
expression is a stable feature through-
out the extended second telogen; clock
genes are required for the correct
timing of the initiation of the second
anagen (Lin et al., 2009). Overrepre-
sentation of cholesterol metabolic pro-
cesses is intriguing as pilosebaceous
units both synthesize and metabolize
steroid hormones such as estrogens,
androgens, and cortisol, all of which
profoundly modulate hair growth. Lo-
cally produced steroid hormones such
as estrogens, which arrest murine HFs
in telogen, may have a role in either
maintaining telogen or in preparing the
HF for anagen activation (Stenn and
Paus, 2001).
Among the genes in cluster I, the
most intriguing example is adipocyte
enhancer binding protein 1 (Aebp1),
known to regulate cholesterol efflux
and MAPK signaling (Majdalawieh and
Ro, 2010), with at least 7-fold higher
expression in telogen compared with all
other hair cycle stages (Figure 1c).
Absent in anagen skin, the Aebp1
protein is expressed most prominently
in the lower telogen HF epithelium
(bulge, secondary hair germ) pointing to
Aebp1 as a potential regulator, to our
knowledge, previously unreported, of
telogen HFs (Figure 1d); Aebp1 is also
expressed in basal epidermal keratino-
cytes. Another intriguing gene in cluster I
is Keratin 24; its prominent upregula-
tion in telogen (Figure 1c) is unex-
pected as most previously investigated
hair keratins show minimal telogen
expression. While the Keratin 24
protein is expressed at a low level
in anagen VI HFs (Figure 1e), its
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Figure 1. Definition of the telogen gene expression signature and dynamic gene expression across the second telogen. (a) Heatmap of the 425-gene
telogen expression signature across the hair cycle. Numbers on top represent postnatal days. Clusters I, II, and III are indicated. (b) Significant (Po0.01)
gene ontology categories for clusters in a. (c) Quantitative PCR (qPCR) validation of the expression of the indicated genes. (d) Immunolocalization of Aebp1
and (e) Keratin 24 in skin. Bar¼ 100 mm. (f) Heatmap of the 376 genes differentially regulated across telogen. Numbers on top represent postnatal days.
Clusters 1–6 are indicated. (g) Significant (Po0.01) gene ontology categories for the clusters in f. (h) qPCR validation of the expression of the indicated genes.
Y axes, relative mRNA levels; X axes, postnatal days; *, pigmented hair shaft; Aebp1, adipocyte enhancer binding protein 1; Defb8, defensin b8; Krt24,
Keratin 24; Plac9, placenta-specific 9; Thbs2, thrombospondin 2; Vwa2, von Willebrand factor-A domain-containing protein 2.
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expression in the infundibulum, isth-
mus, bulge, and secondary hair germ
of telogen HF increases dramatically
compared with anagen; also epidermal
Keratin 24 expression appears to in-
crease during telogen. This telogen-
enriched expression pattern suggests
new hair cycle–regulatory functions
for this ‘‘structural’’ protein, perhaps
comparable to those already identified
for K17 (Tong and Coulombe,
2006).
Two additional clusters encompass
the downregulated telogen signature
genes. Cell cycle–regulatory genes
comprise the major functional category
in Cluster II. Some of the downregu-
lated genes include key components of
G2-M progression: Cdk1, Cdca2, Nek2,
Cenpf, Cenpn, and SMC2. Although the
cell cycle is essentially shut down in the
terminal anagen hair matrix immedi-
ately prior to catagen initiation (most
cell cycle regulators are already very
low in catagen) (Lin et al., 2009), it is
intriguing to note that G2-M transition
seems to be further inhibited in telogen.
Possibly, this is due to the arrest of
some bulge stem cells in G2, perhaps to
enable fast anagen activation (Morris
et al., 2004).
Cluster III contains genes related to
general RNA processing and skin mor-
phogenesis. Among genes involved in
RNA processing are splicing factors
including Ppil1 and Sfrs1, and RNA
degradation factors including Eri1. In-
terestingly, Ppil1 has been shown to
promote epithelial cellular proliferation
in vitro (Obama et al., 2006). Its
downregulation in telogen may relate
to its yet unexplored effects on kerati-
nocyte proliferation in anagen. The
expression of this gene is highest in
anagen, going down more than 2-fold
in late catagen. Eri1, expressed most
highly in the nucleolus, has an impor-
tant role in ribosomal RNA processing
(Ansel et al., 2008). Its reduced telogen
expression may relate to overall re-
duced translational activity in telogen.
Sfrs1 is a splicing factor with many
diverse RNA targets including mRNAs,
miRNAs, snoRNAs, and ncRNAs
(Sanford et al., 2009). Downregulation
of this gene possibly reflects overall
reduction in transcriptional activity in
telogen.
Several differentially regulated genes
lie outside these functional categories,
suggesting additional biological pro-
cesses in telogen. For example, we
show here that Fgf18, a recently identi-
fied inhibitor of anagen initiation se-
creted by K6-positive bulge residents
(Hsu et al., 2011), is upregulated in
telogen (Supplementary Table S1 on-
line). This is consistent with its role in
maintaining bulge quiescence (Hsu
et al., 2011). In addition, we show that
a member of the b-defensin family,
Defb8, is upregulated more than 300-
fold during the second telogen (Figure
1c). This suggests new growth-inhibi-
tory functions of this antimicrobial
peptide, and raises the question
whether Defb8 participates in the
marked signaling shift from a predomi-
nantly immunoinhibitory signaling mi-
lieu of murine anagen skin to one that
greatly facilitates the elicitation of type
IV immune responses in telogen skin
(Stenn and Paus, 2001).
In the second part of this project,
we tested whether whole skin gene
expression is dynamic over the second
telogen; analysis of variance was per-
formed to define genes exhibiting differ-
ential expression over the three telogen
time points (P44, P54, and P59), thus
identifying 376 genes (Supplementary
Methods online, Supplementary Figure
S1 online, and Supplementary Table S2
online). These genes fell into six major
clusters (Figure 1f) featuring enrichment
of specific biological categories (Figure
1g). We validated the expression of
three of these genes by quantitative
PCR. Placenta-specific 9 (cluster 2), a
placenta enriched gene with unknown
functions in skin, has highest expression
in early telogen (Figure 1h). Thrombos-
pondin-2 (cluster 5), an extracellular
matrix regulator, has highest expression
in mid- and late telogen (Figure 1h).
Interestingly, Thrombospondin-1 had
already been found to be instrumental
for inducing the catagen-associated
regression of the HF vasculature, and
Thbs-1 knockout mice showed pro-
longed anagen duration (Yano et al.,
2003). von Willebrand factor A domain-
containing protein 2 (cluster 6), an
extracellular matrix–associated protein
implicated in cell adhesion, has striking
upregulation in mid-telogen (Figure 1h).
It is tempting to speculate that latter
may be involved in b1-integrin-depen-
dent signaling through RGD motif con-
taining ligands that keep bulge and
SHG stem cells in a state of relative
quiescence during telogen (Brakebusch
et al., 2000).
In summary, it is timely to abandon
the often reverberated notion that telogen
constitutes the HF’s ‘‘resting stage’’. By
defining a unique gene expression signa-
ture for telogen mouse skin, the current
work fully supports the concept that,
despite its deceptively ‘‘quiescent’’ mor-
phological appearance, telogen repre-
sents a biologically, very active phase of
HF cycling (Davis, 1962; Stenn and Paus,
2001; Plikus et al., 2008; Greco et al.,
2009; Higgins et al., 2009). More speci-
fically, our data indicate that telogen is
characterized by enhanced cholesterol
and steroid metabolism, skin immune
status, and circadian clock function
(Supplementary Figure S2 online). We
also identify AEBP1, keratin 24, Thsb-2,
and Defb8 as promising new markers
and potential regulators of telogen.
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TO THE EDITOR
A major concern when surveying phy-
sicians via mailed questionnaires is the
potential raised by low response rates
for nonresponse bias (i.e., the possibi-
lity that those individuals who com-
plete a survey are different in some way
than those who do not complete a
survey; Tambor et al., 1993; Halpern
et al., 2002). While low response rates
do not automatically lead to this type of
bias, the possibility for nonresponse
bias is higher when the response rate
is low (Cummings et al., 2001; Halpern
and Asch, 2003).
Three interventions that may in-
crease response rates and that have
not yet been adequately investigated
are hand-written personalized notes on
the introductory cover letter accompa-
nying the survey instrument, hand-
written signatures and notes on a
reminder postcard, and inclusion of
hard candy in mailings as a material
incentive. We investigated the effect of
these three interventions in a mailed
survey of 800 dermatologists randomly
assigned to groups that would either
receive or not receive each of the three
interventions (Table 1). This study was
approved by the Institutional Review
Board of the University of Pennsylvania
School of Medicine. We mailed a four-
page survey on physician attitudes and
beliefs surrounding dysplastic nevi to
800 randomly selected members of the
American Academy of Dermatology
with mailing addresses in the United
States. (The results of the survey and
additional details regarding the survey
instrument can be found in Shapiro
et al., 2004.) Our mailing protocol, a
modification of the Dillman Tailored
Design Method (Dillman, 1999), in-
cluded an initial mailing of a cover
letter and survey, a reminder postcard
sent 1–2 weeks later, and a second
mailing of the survey to those who
had not yet responded approximately
6 weeks after the initial mailing. The
initial cover letter included the recipi-
ent’s name and address and a brief
summary of the study, and it concluded
with preprinted signatures of the inves-
tigators.
Subjects were randomly assigned to
one of the eight groups using a
222 factorial design (Table 1) so
that half of the subjects received a
personalized hand-written note on the
cover letter for the initial mailing and
half did not; half of the subjects
received three hard candies (large-size
LifeSavers ‘‘Wintogreen’’ mints, indivi-
dually wrapped, each B2.5 cm in
diameter) in the initial mailing and half
did not; and half of the subjects
received a reminder postcard with a
hand-written signature with ‘‘Thank
you!’’ hand-written next to it, while
the other half received a reminder
postcard containing a preprinted signa-
ture only. The personalized note in
the initial mailing was at the top of
the cover letter, personally addressed to
the recipient, with the following hand-
written text: ‘‘Dear Dr XX, We’d greatly
appreciate your participation. Sin-
cerely, Michael Ming,’’ with Dr Ming’s
hand-written signature. The second
mailing of the survey did not contain
the personalized note or the hard
candy.
Comparisons were made by w2-analy-
sis using Stata 6.0 (Stata, College Station,
TX). With 400 subjects in each interven-
tion and control group, the study had
81% power at the level of a¼0.05 to
detect a difference of at least 10% from a
baseline response rate of 50%.
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